AI-Driven Design of Antimicrobial Peptide for Combating Resistance and Infectious Diseases

Researchers used artificial intelligence and machine learning to design a novel short antimicrobial peptide, LCN-15, as a potential alternative to traditional antibiotics. The peptide was optimized in silico for effectiveness and safety, showing predicted broad antimicrobial, anti-biofilm, anticancer, antioxidant, and immunomodulatory properties, while also demonstrating low toxicity and good biological stability. By validating their approach against a well-known peptide (Melittin), the study supports the reliability of AI-driven design. Overall, LCN-15 emerges as a promising, multifunctional candidate that could help address antimicrobial resistance while reducing development time and costs through computational pre-screening.